[{"address1": "27 West 24th Street", "address2": "Suite 702", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "646 481 9832", "website": "https://www.tourmalinebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York. Tourmaline Bio, Inc. operates as a subsidiary of Novartis AG.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sandeep C. Kulkarni M.D.", "age": 42, "title": "Co-Founder, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 848250, "exercisedValue": 0, "unexercisedValue": 3257194}, {"maxAge": 1, "name": "Mr. Ryan  Robinson CPA", "age": 36, "title": "CFO & Treasurer", "yearBorn": 1988, "fiscalYear": 2024, "totalPay": 575855, "exercisedValue": 0, "unexercisedValue": 276336}, {"maxAge": 1, "name": "Mr. W. Bradford Middlekauff J.D.", "age": 62, "title": "Chief Business Officer, General Counsel & Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 582250, "exercisedValue": 0, "unexercisedValue": 727921}, {"maxAge": 1, "name": "Dr. Susan Dana Jones Ph.D.", "age": 64, "title": "Chief Technology Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly  Piorkowski", "title": "Vice President of People, Culture & Compliance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin B. Johnson M.B.A., Ph.D.", "age": 60, "title": "Chief Regulatory Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 555835, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dora  Rau", "title": "Senior VP & Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Hagn Pharm.D.", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil M. deGoma M.D.", "title": "Senior Vice President of Medical Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristine  Erickson O.D., Ph.D.", "title": "VP & TA Head of Ophthalmology, Medical Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 47.98, "open": 47.98, "dayLow": 47.98, "dayHigh": 47.98, "regularMarketPreviousClose": 47.98, "regularMarketOpen": 47.98, "regularMarketDayLow": 47.98, "regularMarketDayHigh": 47.98, "payoutRatio": 0.0, "beta": 1.581, "forwardPE": -11.30271, "volume": 774981, "regularMarketVolume": 774981, "averageVolume": 1011448, "averageVolume10days": 720048, "averageDailyVolume10Day": 720048, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 1232715008, "fiftyTwoWeekLow": 11.56, "fiftyTwoWeekHigh": 48.27, "allTimeHigh": 48.31, "allTimeLow": 9.18, "fiftyDayAverage": 42.226, "twoHundredDayAverage": 23.144175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 993626048, "profitMargins": 0.0, "floatShares": 13127464, "sharesOutstanding": 25692268, "sharesShort": 808958, "sharesShortPriorMonth": 1633468, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0315, "heldPercentInsiders": 0.14616999, "heldPercentInstitutions": 0.89125997, "shortRatio": 1.12, "shortPercentOfFloat": 0.0352, "impliedSharesOutstanding": 25692268, "bookValue": 10.088, "priceToBook": 4.756146, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -88474000, "trailingEps": -3.44, "forwardEps": -3.64, "enterpriseToEbitda": -9.703, "52WeekChange": 0.8271135, "SandP52WeekChange": 0.14261019, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TRML", "underlyingSymbol": "TRML", "shortName": "Tourmaline Bio, Inc.", "longName": "Tourmaline Bio, Inc.", "firstTradeDateEpochUtc": 1697808600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f54121ba-87b6-3e2f-98f1-0816320876db", "messageBoardId": "finmb_1843009393", "gmtOffSetMilliseconds": -18000000, "currentPrice": 47.98, "targetHighPrice": 48.0, "targetLowPrice": 48.0, "targetMeanPrice": 48.0, "targetMedianPrice": 48.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 239234000, "totalCashPerShare": 9.312, "ebitda": -102406000, "totalDebt": 145000, "quickRatio": 23.698, "currentRatio": 24.676, "debtToEquity": 0.056, "returnOnAssets": -0.20854001, "returnOnEquity": -0.29615998, "freeCashflow": -53317624, "operatingCashflow": -86276000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]